Technical Analysis for STIM - Neuronetics, Inc.

Grade Last Price % Change Price Change
grade C 19.16 -4.63% -0.93
STIM closed down 4.63 percent on Monday, December 17, 2018, on 1.67 times normal volume.
1 Watcher
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Down
See historical STIM trend table...

Date Alert Name Type % Chg
Dec 17 Multiple of Ten Bearish Other 0.00%
Dec 14 NR7 Range Contraction -4.63%
Dec 14 Multiple of Ten Bullish Other -4.63%
Dec 13 Multiple of Ten Bearish Other -3.77%
Dec 13 Overbought Stochastic Strength -3.77%
Dec 12 Bearish Engulfing Bearish -2.54%
Dec 12 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.54%
Dec 12 Multiple of Ten Bearish Other -2.54%
Dec 12 Inside Day Range Contraction -2.54%
Dec 12 Overbought Stochastic Strength -2.54%

Older signals for STIM ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
Basic chart:
Profile
  • Earnings date: 2018-11-06
Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
Is STIM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 27 At FDA, a new goal, then a push for speedy device reviews
Nov 26 Neuronetics Is Undervalued, There Seems To Be A 40% Upside Potential
Nov 23 50 Biggest Movers From Wednesday
Nov 20 The Daily Biotech Pulse: Denali's Positive Results, Novartis' Substance Abuse Therapy Launch, Medtronic Earnings
Nov 15 The Daily Biotech Pulse: FDA Nod For Mallinckrodt's Pain Drug, AbbVie-Neurocrine Report Positive Elagolix Results
Nov 15 Neuronetics to Present at the 30th Annual Piper Jaffray Healthcare Conference
Nov 13 NeuroStar® Advanced Therapy and Transformations TMS Expanding Partnership to Increase Patient Access to Depression Treatment
Nov 11 Neuronetics (STIM) CEO Chris Thatcher on Q3 2018 Results - Earnings Call Transcript
Nov 6 Neuronetics: 3Q Earnings Snapshot
Nov 6 Neuronetics beats by $0.15, beats on revenue
See more STIM news...
Indicators
Indicator Value
52 Week High 39.39
52 Week Low 15.4
Average Volume 127,128
200-Day Moving Average 0.0
50-Day Moving Average 21.8246
20-Day Moving Average 18.538
10-Day Moving Average 19.548
Average True Range 1.5189
ADX 21.79
+DI 18.3812
-DI 18.8994
Chandelier Exit (Long, 3 ATRs ) 17.7233
Chandelier Exit (Short, 3 ATRs ) 19.9567
Upper Bollinger Band 21.0565
Lower Bollinger Band 16.0195
Percent B (%b) 0.62
BandWidth 27.171216
MACD Line -0.6273
MACD Signal Line -1.0578
MACD Histogram 0.4305
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.10
Resistance 3 (R3) 21.26 20.77 20.77
Resistance 2 (R2) 20.77 20.28 20.69 20.66
Resistance 1 (R1) 19.97 19.98 19.73 19.81 20.56
Pivot Point 19.48 19.48 19.36 19.40 19.48
Support 1 (S1) 18.68 18.99 18.44 18.52 17.76
Support 2 (S2) 18.19 18.69 18.11 17.66
Support 3 (S3) 17.39 18.19 17.55
Support 4 (S4) 17.23